During pandemic, growth of clinicians with X-waivers for buprenorphine prescribing slowed

The growth in the number of clinicians with waivers to prescribe buprenorphine slowed during the pandemic, and support and mentorship are needed to facilitate obtaining a waiver, according to two studies published online May 12 in JAMA Network Open.

This article was originally published on MedicalXpress.com

Read More: